(Q35172268)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Marie-Christine Galas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Serge N. Schiffmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Raphaël Hourez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Patrizia Popoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

366-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12849153%20AND%20SRC:MED&resulttype=core&format=json

Differential loss of striatal projection neurons in Huntington disease

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Cortical and striatal neurone number in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

A polymorphic DNA marker genetically linked to Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Calpain activation in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Transcriptional dysregulation in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Wild-type huntingtin protects from apoptosis upstream of caspase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Loss of normal huntingtin function: new developments in Huntington's disease research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Replicating Huntington's disease phenotype in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Maintained improvement with minocycline of a patient with advanced Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Fetal tissue transplants in animal models of Huntington's disease: the effects on damaged neuronal circuitry and behavioral deficits

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Motor and cognitive improvements in patients with Huntington's disease after neural transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The role and regulation of adenosine in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Brain regional levels of adenosine and adenosine nucleotides in rats killed by high-energy focused microwave irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Extracellular metabolism of ATP and other nucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Release of adenosine by activation of NMDA receptors in the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuroprotective role of adenosine in cerebral ischaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

A cloned G protein-coupled protein with a distribution restricted to striatal medium-sized neurons. Possible relationship with D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

How does adenosine inhibit transmitter release?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

New aspects of physiological and pathophysiological functions of adenosine A2A receptor in basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuronal cell death in Huntington's disease: a potential role for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine: does it have a neuroprotective role after all?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Opposite effects of cyclohexyladenosine and theophylline on hypoxic damage in cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neurotoxicity in organotypic hippocampal slices mediated by adenosine analogues and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine receptor ligands: differences with acute versus chronic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Hypoxia produces cell death in the rat hippocampus in the presence of an A1 adenosine receptor antagonist: An anatomical and behavioral study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine antagonists alter the synaptic response to in vitro ischemia in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Modulation of nerve and glial function by adenosine--role in the development of ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Functional characterization of adenosine receptors in the nucleus tractus solitarius mediating hypotensive responses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Inactivation of adenosine A2A receptor impairs long term potentiation in the accumbens nucleus without altering basal synaptic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Distribution, biochemistry and function of striatal adenosine A2A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

The selective vulnerability of striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Acute dyskinesias in young asthmatics treated with theophylline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Choreiform movements observed in an 8-year-old child following use of an oral theophylline preparation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

CGS 21680 exerts marked antidystonic effects in a genetic model of paroxysmal dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Striatal A2A adenosine receptors differentially regulate spontaneous and K+-evoked glutamate release in vivo in young and aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

SCH 58261 (an adenosine A(2A) receptor antagonist) reduces, only at low doses, K(+)-evoked glutamate release in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Early and progressive accumulation of reactive microglia in the Huntington disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine extracellular brain concentrations and role of A2A receptors in ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Central versus peripheral mediation of responses to adenosine receptor agonists: evidence against a central mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine as an antiarrhythmic agent

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Cardiovascular and antilipolytic effects of the adenosine agonist GR79236

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Characterization of the adenosine receptors mediating hypothermia in the conscious mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021

Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900411-3

7 January 2021